Cargando…
GRAde: a long-read sequencing approach to efficiently identifying the CYP11B1/CYP11B2 chimeric form in patients with glucocorticoid-remediable aldosteronism
BACKGROUND: Glucocorticoid-remediable aldosteronism (GRA) is a form of heritable hypertension caused by a chimeric fusion resulting from unequal crossing over between 11β‐hydroxylase (CYP11B1) and aldosterone synthase (CYP11B2), which are two genes with similar sequences. Different crossover pattern...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8750845/ https://www.ncbi.nlm.nih.gov/pubmed/35012455 http://dx.doi.org/10.1186/s12859-022-04561-w |
_version_ | 1784631553113980928 |
---|---|
author | Wu, Yu-Ching Chen, Chia-I Chen, Peng-Ying Kuo, Chun-Hung Hung, Yi-Hsuan Peng, Kang-Yung Wu, Vin-Cent Tsai-Wu, Jyy-Jih Hsu, Chia-Lang |
author_facet | Wu, Yu-Ching Chen, Chia-I Chen, Peng-Ying Kuo, Chun-Hung Hung, Yi-Hsuan Peng, Kang-Yung Wu, Vin-Cent Tsai-Wu, Jyy-Jih Hsu, Chia-Lang |
author_sort | Wu, Yu-Ching |
collection | PubMed |
description | BACKGROUND: Glucocorticoid-remediable aldosteronism (GRA) is a form of heritable hypertension caused by a chimeric fusion resulting from unequal crossing over between 11β‐hydroxylase (CYP11B1) and aldosterone synthase (CYP11B2), which are two genes with similar sequences. Different crossover patterns of the CYP11B1 and CYP11B2 chimeric genes may be associated with a variety of clinical presentations. It is therefore necessary to develop an efficient approach for identifying the differences between the hybrid genes of a patient with GRA. RESULTS: We developed a long-read analysis pipeline named GRAde (GRA deciphering), which utilizes the nonidentical bases in the CYP11B1 and CYP11B2 genomic sequences to identify and visualize the chimeric form. We sequenced the polymerase chain reaction (PCR) products of the CYP11B1/CYP11B2 chimeric gene from 36 patients with GRA using the Nanopore MinION device and analyzed the sequences using GRAde. Crossover events were identified for 30 out of the 36 samples. The crossover sites appeared in the region exhibiting high sequence similarity between CYP11B1 and CYP11B2, and 53.3% of the cases were identified as having a gene conversion in intron 2. More importantly, there were six cases for whom the PCR products indicated a chimeric gene, but the GRAde results revealed no crossover pattern. The crossover regions were further verified by Sanger sequencing analysis. CONCLUSIONS: PCR-based target enrichment followed by long-read sequencing is an efficient and precise approach to dissecting complex genomic regions, such as those involved in GRA mutations, which could be directly applied to clinical diagnosis. The scripts of GRAde are available at https://github.com/hsu-binfo/GRAde. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12859-022-04561-w. |
format | Online Article Text |
id | pubmed-8750845 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-87508452022-01-11 GRAde: a long-read sequencing approach to efficiently identifying the CYP11B1/CYP11B2 chimeric form in patients with glucocorticoid-remediable aldosteronism Wu, Yu-Ching Chen, Chia-I Chen, Peng-Ying Kuo, Chun-Hung Hung, Yi-Hsuan Peng, Kang-Yung Wu, Vin-Cent Tsai-Wu, Jyy-Jih Hsu, Chia-Lang BMC Bioinformatics Methodology BACKGROUND: Glucocorticoid-remediable aldosteronism (GRA) is a form of heritable hypertension caused by a chimeric fusion resulting from unequal crossing over between 11β‐hydroxylase (CYP11B1) and aldosterone synthase (CYP11B2), which are two genes with similar sequences. Different crossover patterns of the CYP11B1 and CYP11B2 chimeric genes may be associated with a variety of clinical presentations. It is therefore necessary to develop an efficient approach for identifying the differences between the hybrid genes of a patient with GRA. RESULTS: We developed a long-read analysis pipeline named GRAde (GRA deciphering), which utilizes the nonidentical bases in the CYP11B1 and CYP11B2 genomic sequences to identify and visualize the chimeric form. We sequenced the polymerase chain reaction (PCR) products of the CYP11B1/CYP11B2 chimeric gene from 36 patients with GRA using the Nanopore MinION device and analyzed the sequences using GRAde. Crossover events were identified for 30 out of the 36 samples. The crossover sites appeared in the region exhibiting high sequence similarity between CYP11B1 and CYP11B2, and 53.3% of the cases were identified as having a gene conversion in intron 2. More importantly, there were six cases for whom the PCR products indicated a chimeric gene, but the GRAde results revealed no crossover pattern. The crossover regions were further verified by Sanger sequencing analysis. CONCLUSIONS: PCR-based target enrichment followed by long-read sequencing is an efficient and precise approach to dissecting complex genomic regions, such as those involved in GRA mutations, which could be directly applied to clinical diagnosis. The scripts of GRAde are available at https://github.com/hsu-binfo/GRAde. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12859-022-04561-w. BioMed Central 2022-01-10 /pmc/articles/PMC8750845/ /pubmed/35012455 http://dx.doi.org/10.1186/s12859-022-04561-w Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Methodology Wu, Yu-Ching Chen, Chia-I Chen, Peng-Ying Kuo, Chun-Hung Hung, Yi-Hsuan Peng, Kang-Yung Wu, Vin-Cent Tsai-Wu, Jyy-Jih Hsu, Chia-Lang GRAde: a long-read sequencing approach to efficiently identifying the CYP11B1/CYP11B2 chimeric form in patients with glucocorticoid-remediable aldosteronism |
title | GRAde: a long-read sequencing approach to efficiently identifying the CYP11B1/CYP11B2 chimeric form in patients with glucocorticoid-remediable aldosteronism |
title_full | GRAde: a long-read sequencing approach to efficiently identifying the CYP11B1/CYP11B2 chimeric form in patients with glucocorticoid-remediable aldosteronism |
title_fullStr | GRAde: a long-read sequencing approach to efficiently identifying the CYP11B1/CYP11B2 chimeric form in patients with glucocorticoid-remediable aldosteronism |
title_full_unstemmed | GRAde: a long-read sequencing approach to efficiently identifying the CYP11B1/CYP11B2 chimeric form in patients with glucocorticoid-remediable aldosteronism |
title_short | GRAde: a long-read sequencing approach to efficiently identifying the CYP11B1/CYP11B2 chimeric form in patients with glucocorticoid-remediable aldosteronism |
title_sort | grade: a long-read sequencing approach to efficiently identifying the cyp11b1/cyp11b2 chimeric form in patients with glucocorticoid-remediable aldosteronism |
topic | Methodology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8750845/ https://www.ncbi.nlm.nih.gov/pubmed/35012455 http://dx.doi.org/10.1186/s12859-022-04561-w |
work_keys_str_mv | AT wuyuching gradealongreadsequencingapproachtoefficientlyidentifyingthecyp11b1cyp11b2chimericforminpatientswithglucocorticoidremediablealdosteronism AT chenchiai gradealongreadsequencingapproachtoefficientlyidentifyingthecyp11b1cyp11b2chimericforminpatientswithglucocorticoidremediablealdosteronism AT chenpengying gradealongreadsequencingapproachtoefficientlyidentifyingthecyp11b1cyp11b2chimericforminpatientswithglucocorticoidremediablealdosteronism AT kuochunhung gradealongreadsequencingapproachtoefficientlyidentifyingthecyp11b1cyp11b2chimericforminpatientswithglucocorticoidremediablealdosteronism AT hungyihsuan gradealongreadsequencingapproachtoefficientlyidentifyingthecyp11b1cyp11b2chimericforminpatientswithglucocorticoidremediablealdosteronism AT pengkangyung gradealongreadsequencingapproachtoefficientlyidentifyingthecyp11b1cyp11b2chimericforminpatientswithglucocorticoidremediablealdosteronism AT wuvincent gradealongreadsequencingapproachtoefficientlyidentifyingthecyp11b1cyp11b2chimericforminpatientswithglucocorticoidremediablealdosteronism AT tsaiwujyyjih gradealongreadsequencingapproachtoefficientlyidentifyingthecyp11b1cyp11b2chimericforminpatientswithglucocorticoidremediablealdosteronism AT hsuchialang gradealongreadsequencingapproachtoefficientlyidentifyingthecyp11b1cyp11b2chimericforminpatientswithglucocorticoidremediablealdosteronism AT gradealongreadsequencingapproachtoefficientlyidentifyingthecyp11b1cyp11b2chimericforminpatientswithglucocorticoidremediablealdosteronism |